Photo of Margaret Wood Hassan
D United States Senate · New Hampshire

Sen. Margaret Wood Hassan

Compare
Total votes
1,044
all sessions
Attendance
99%
7 missed
Near the chamber average
With party
95%
of cast votes
Lower than 82% of chamber peers
Bipartisan score
3%
crosses aisle rarely
Higher than 80% of chamber peers
Sponsored
1,389
bills & resolutions
Near the chamber average
Committees
12
assignments
1,389 bills and resolutions

Sponsored bills

Total
1,389
Primary
196
Co-sponsor
1,193
This page
1,389
matching current filters
Co-sponsor S 2355
In committee · Indiana Senate · Co-sponsor
Patients Deserve Price Tags Act

Maddy summaryThe Patients Deserve Price Tags Act requires hospitals, clinical diagnostic laboratories, imaging services providers, and ambulatory surgical centers to publicly disclose detailed pricing information for healthcare services in machine-readable formats. This includes standard charges, discounted cash prices, payer-specific negotiated rates, and other relevant pricing data that consumers can easily access and compare. The law applies to all facilities that provide services to Medicare beneficiaries, with implementation dates starting in 2026 for hospitals and 2027 for other providers. Non-compliant facilities face daily civil monetary penalties ranging from $300 to $10,000 per day, depending on facility size and duration of non-compliance.

In committee Jul 27, 2026 1 co-sponsor
Co-sponsor S 1954
In committee · Indiana Senate · Co-sponsor
Biosimilar Red Tape Elimination Act

Maddy summaryThis bill simplifies the approval process for biosimilar drugs - medicines that are highly similar to, but not identical to, existing biologic drugs. It amends the Public Health Service Act to clarify when biosimilars are deemed "interchangeable" with the original drug (allowing pharmacists to substitute them without a doctor's specific order), adjusts exclusivity periods for existing biosimilars, and sets a 60-day transition period after enactment. The bill also requires the FDA to update its guidance documents within 18 months to reflect these changes. This directly affects pharmaceutical companies developing biosimilars, the FDA in its review process, and ultimately patients seeking more affordable treatment options.

In committee Jul 27, 2026 1 co-sponsor
Co-sponsor S 1414
In committee · Indiana Senate · Co-sponsor
Expedited Access to Biosimilars Act

Maddy summaryThis bill modifies requirements for approving biosimilar drugs (follow-on versions of biologic medicines). It removes previous mandatory assessments of immunogenicity or clinical efficacy for biosimilar licensure, instead allowing the FDA to require such studies only when the agency provides written justification to the applicant. The change applies to new biosimilar applications submitted after the bill's enactment. It directly affects drug manufacturers seeking FDA approval for biosimilars and the FDA's review process, aiming to streamline approvals while maintaining safety standards.

In committee Jul 27, 2026 1 co-sponsor
Co-sponsor S 5108
In committee · Indiana Senate · Co-sponsor
Right to IVF Act of 2026

Maddy summaryThe Right to IVF Act of 2026 establishes federal protections to ensure individuals can access assisted reproductive technology and intrauterine insemination without state-imposed restrictions, while also mandating that health insurance plans, Medicare, Medicaid, and the Federal Employees Health Benefits program cover these services. The bill defines these procedures broadly to include treatments like egg and embryo freezing and requires coverage regardless of whether a patient has been diagnosed with infertility. It further directs the Department of Defense and the Department of Veterans Affairs to provide fertility preservation and reproductive assistance to uniformed service members and veterans, including funding for egg or sperm retrieval and storage. Additionally, the legislation grants federal courts the authority to challenge and block any state laws that limit access to these reproductive treatments or discriminate against providers and patients based on protected characteristics.

In committee Jul 23, 2026 1 co-sponsor
Co-sponsor S 5075
In committee · Indiana Senate · Co-sponsor
Get Foreign Money Out of U.S. Elections Act

Maddy summaryThis bill expands existing rules to prevent foreign nationals from influencing U.S. elections by tightening restrictions on domestic businesses that are owned or controlled by foreign interests. It requires companies with significant foreign ownership or control to file a sworn certification confirming they are not foreign entities before making any political contributions or spending money on election activities. Additionally, the law prohibits recipients of these funds from using them for further political spending unless they receive and verify the original certification, while also clarifying that these rules apply to state and local ballot measures as well as corporate political committees.

In committee Jul 22, 2026 1 co-sponsor
Primary S 5067
In committee · Indiana Senate · Lead sponsor
Federal Cybersecurity Workforce Expansion Act

Maddy summaryThe Federal Cybersecurity Workforce Expansion Act aims to address the national shortage of qualified cybersecurity personnel by creating two new pilot programs within the Department of Homeland Security. The first initiative establishes an apprenticeship program that hires up to 25 individuals annually to gain on-the-job training and related education, with the goal of placing them in permanent federal cyber workforce positions after completion. The second program offers free cybersecurity training to veterans and military spouses, providing virtual and hands-on learning opportunities that lead to recognized postsecondary credentials. Both pilots include provisions for recruiting underrepresented communities and require regular reporting to Congress on participant demographics, completion rates, and employment outcomes. Additionally, the bill extends the deadline for a federal cybersecurity workforce assessment from 2022 to 2028 to better track staffing needs.

In committee Jul 22, 2026 0 co-sponsors
Primary S 5065
In committee · Indiana Senate · Lead sponsor
Help Grandfamilies Prevent Child Abuse Act

Maddy summaryThe Help Grandfamilies Prevent Child Abuse Act updates the Child Abuse Prevention and Treatment Act to better support children raised by relatives or close family friends outside the foster care system. It requires states receiving federal grants to prioritize placing children with kin, license relatives as foster parents, and create community networks to assist these families. The bill also mandates that state programs include specific training for kinship caregivers on handling behavioral challenges, substance use disorders, and trauma. Additionally, it expands the advisory board and national information clearinghouse to include organizations serving kinship families and the perspectives of birth parents and former foster youth.

In committee Jul 22, 2026 0 co-sponsors
Co-sponsor SCONRES 36
In committee · Indiana Senate · Co-sponsor
A concurrent resolution recognizing the significance of equal pay and the disparity in wages paid to men and to Black women.

Maddy summaryThis concurrent resolution formally recognizes the significant wage gap between Black women and white, non-Hispanic men in the United States. The document cites data showing that Black women earn roughly 65 cents for every dollar earned by white men and highlights how this disparity impacts their ability to support families and accumulate wealth. By referencing existing laws like the Equal Pay Act and the Civil Rights Act, the bill reaffirms Congress's support for equal pay for equal work without proposing new legislation or policy changes. Ultimately, the measure serves as a symbolic acknowledgment of the economic challenges faced by Black women due to dual discrimination based on race and gender.

In committee Jul 21, 2026 1 co-sponsor
Co-sponsor S 5043
In committee · Indiana Senate · Co-sponsor
Secure Drug Supply Chain Act of 2026

Maddy summaryThe Secure Drug Supply Chain Act of 2026 aims to protect the U.S. pharmaceutical supply by preventing the importation of counterfeit or unsafe drugs from countries like China and others designated as adversarial. It requires drug manufacturers to report quarterly details about the origins of their active ingredients and key starting materials, specifically highlighting those sourced from China or other foreign countries of concern. The bill also strengthens enforcement by allowing the government to ban imports from facilities using forced labor or violating sanctions, and it mandates the destruction of refused drugs that pose significant public health risks. Additionally, the law establishes new reporting requirements to track supply chain vulnerabilities and directs the Health and Human Services Secretary to issue regulations and guidance to implement these measures.

In committee Jul 21, 2026 1 co-sponsor
Co-sponsor SRES 801
Passed · Indiana Senate · Co-sponsor
A resolution honoring the life and legacy of the Honorable Lindsey Olin Graham, a Senator from the State of South Carolina.

Maddy summaryThis resolution honors the life and legacy of the late Senator Lindsey Olin Graham from South Carolina. It formally acknowledges his extensive career in the military, state government, and Congress, noting his service as a Senator and his roles as Chairman of the Judiciary and Budget committees. The Senate expresses its sorrow over his death and requests that this tribute be shared with the House of Representatives and Graham's family.

Passed Jul 16, 2026 1 co-sponsor
Showing 41 to 50 of 1,389 bills
Previous 1 … 4 5 6 … 139 Next